REVIEW PAPER
Figure from article: Synbiotic Formulations with...
 
KEYWORDS
TOPICS
ABSTRACT
Obesity is an escalating global public-health challenge, closely linked to gut-microbiota dysbiosis and disruption of the gut–brain axis. Intestinal L cells secrete the incretins GLP-1 and PYY, which suppress appetite, slow gastric emptying, and improve glucose–insulin balance. Their activity is strongly modulated by short-chain fatty acids (SCFAs-acetate, propionate, butyrate) generated by fiber fermentation. Via FFAR2/FFAR3 receptors, SCFAs increase GLP-1/PYY secretion, strengthen the intestinal barrier, and dampen low-grade inflammation, enhancing insulin sensitivity and weight control. Growing evidence shows that SCFA-producing probiotics (e.g., Bifidobacterium animalis, Clostridium butyricum, Butyricimonas virosa), fermentable prebiotics (inulin/FOS), and polyphenols can synergistically potentiate this pathway. Polyphenols act through two routes: direct activation of L cells (taste/GPCR signaling) and indirect promotion of SCFA production by reshaping the microbiota. This review examines the potential for developing a functional symbiotic, combining SCFAs producing strains with an appropriate prebiotic and bioactive polyphenols as a natural strategy to enhance appetite regulation, glycemic control, and energy homeostasis through modulation of the GLP-1/PYY pathway. Keywords: GLP-1, short-chain fatty acids, obesity, probiotics, satiety hormone regulation
eISSN:3071-7264
ISSN:3071-7256
Journals System - logo
Scroll to top